The standard treatment for any primary bone tumor is complete surgical resection; however, in selected cases, treatment with the receptor activator of nuclear factor kappa-B ligand (RANK-L) inhibitor denosumab, bisphosphonate therapy, or even radiation therapy may be employed. Here, TNFSF11 is linked to bone neoplasm.